Rutgers Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick, NJ 08903-2681
732-235-CINJ (2465)
Program Leaders: Eileen White, PhD and Wei-Xing Zong, PhD
To determine how oncogenic alterations regulate tumor cell metabolism, growth, proliferation, survival, and tumor-host interaction to facilitate disease progression. The ultimate aim is to identify new approaches to improve cancer treatment through innovative biochemical, molecular and biological research. In vivo approaches to address metabolic, physical and immunologic functions in cancer are a nexus of research within the Program. Development and application of state-of-the-art measurement of cancer metabolism is a signature Program feature that spans the Rutgers/Princeton consortium. The Program provides the platform for productive, collaborative, and impactful science, and interfaces with the Cancer Center for the translation of that science, both bench to bedside and bedside to bench.